Skip to main content
Premium Trial:

Request an Annual Quote

Bottoms Up!

Australian Nobel Laureate Barry Marshall — lauded for his discovery of the stomach-dwelling bacterium Helicobacter pylori's role in gastritis and peptic-ulcer disease — plans to put the bug that made him famous to use in science's battle against the flu, Bloomberg reports. By mid-2013, Marshall said he expects the biotech firm he founded, Ondek Ltd., to report results for a clinical trial of a drinkable flu vaccine. Researchers aim to use the vaccine "to harness the ability of the bacterium … to colonize the stomach," such that its "harmful genes will be removed and those from influenza and other viruses will be inserted to stimulate an immune response," according to Bloomberg. In a preliminary study, Marshall and his team showed that "some [vaccine] strains were capable of safely colonizing the gut, proving the concept is feasible," Bloomberg adds.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.